These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33006025)

  • 1. Moderate hypofractionated radiotherapy for post-operative treatment of prostate cancer: long-term outcome and pattern of toxicity.
    Franzese C; Badalamenti M; Baldaccini D; D'Agostino G; Comito T; Franceschini D; Clerici E; Navarria P; Reggiori G; Tomatis S; Scorsetti M
    Strahlenther Onkol; 2021 Feb; 197(2):133-140. PubMed ID: 33006025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity.
    Fersino S; Tebano U; Mazzola R; Giaj-Levra N; Ricchetti F; Di Paola G; Fiorentino A; Sicignano G; Naccarato S; Ruggieri R; Cavalleri S; Alongi F
    Clin Genitourin Cancer; 2017 Aug; 15(4):e667-e673. PubMed ID: 28237181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial.
    Leite ETT; Ramos CCA; Ribeiro VAB; Salvajoli BP; Nahas WC; Salvajoli JV; Ynoe Moraes F
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1263-1270. PubMed ID: 33346091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis.
    Tamihardja J; Schortmann M; Lawrenz I; Weick S; Bratengeier K; Flentje M; Guckenberger M; Polat B
    Strahlenther Onkol; 2021 Feb; 197(2):124-132. PubMed ID: 32833036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.
    Lewis SL; Patel P; Song H; Freedland SJ; Bynum S; Oh D; Palta M; Yoo D; Oleson J; Salama JK
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):605-11. PubMed ID: 26867889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderately hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer after prostatectomy: long-term results and comparative analysis of two schedules.
    Matrone F; Donofrio A; Fanetti G; Revelant A; Polesel J; Chiovati P; Bortolus R
    Neoplasma; 2022 Dec; 69(6):1425-1436. PubMed ID: 36305692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10-yr Results of Moderately Hypofractionated Postoperative Radiotherapy for Prostate Cancer Focused on Treatment Related Toxicity.
    Castelluccia A; Tramacere F; Colciago RR; Borgia M; Sallustio A; Proto T; Portaluri M; Arcangeli PS
    Clin Genitourin Cancer; 2024 Aug; 22(4):102102. PubMed ID: 38759337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes.
    Ferrera G; D'Alessandro S; Cuccia F; Serretta V; Trapani G; Savoca G; Mortellaro G; Lo Casto A
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):89-95. PubMed ID: 34595542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy.
    Beck M; Wust P; Barelkowski T; Kaul D; Thieme AH; Wecker S; Wlodarczyk W; Budach V; Ghadjar P
    Radiat Oncol; 2017 Aug; 12(1):125. PubMed ID: 28793907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: a secondary analysis of RTOG 0415.
    Carpenter DJ; Salama JK; Lee WR; Boyer MJ
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):95-102. PubMed ID: 36849728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate hypofractionated post-prostatectomy radiation therapy is feasible and well tolerated: experience from a single tertiary cancer centre.
    Valero J; Montero A; Hernando O; Izquierdo M; Sánchez E; García-Aranda M; López M; Ciérvide R; Martí J; Álvarez B; Alonso R; Chen-Zhao X; Fernández-Letón P; Rubio C
    Clin Transl Oncol; 2021 Jul; 23(7):1452-1462. PubMed ID: 33433839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapy.
    Nicosia L; Mazzola R; Vitale C; Cuccia F; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Ruggeri R; Cavalleri S; Alongi F
    Radiol Med; 2022 May; 127(5):560-570. PubMed ID: 35347581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging.
    Rigo M; Mazzola R; Napoli G; Giaj-Levra N; Figlia V; Nicosia L; Ricchetti F; Tomasini D; Bonù ML; Cuccia F; Bellorofonte C; Alongi F
    Radiol Med; 2020 May; 125(5):491-499. PubMed ID: 32077006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of post-prostatectomy radiotherapy at a Regional Cancer Centre.
    Nicholls L; Winter A; Harwood A; Plank A; Bagga P; Wong W; Khoo E
    J Med Radiat Sci; 2017 Dec; 64(4):259-265. PubMed ID: 28805047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer.
    Teh BS; Lewis GD; Mai W; Pino R; Ishiyama H; Butler EB
    Cancer Commun (Lond); 2018 Apr; 38(1):11. PubMed ID: 29764515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated Volumetric Modulated Arc Radiotherapy with simultaneous Elective Nodal Irradiation is feasible in prostate cancer patients: A single institution experience.
    Hegazy MW; Mahmood RI; Al Otaibi MF; Khalil EM
    J Egypt Natl Canc Inst; 2016 Jun; 28(2):101-10. PubMed ID: 27133975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage radiation therapy after radical prostatectomy: survival analysis.
    Galla A; Maggio A; Delmastro E; Garibaldi E; Gabriele P; Bresciani S; Di Dia A; Stasi M; Gabriele D
    Minerva Urol Nefrol; 2019 Jun; 71(3):240-248. PubMed ID: 30037205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
    Ost P; Lumen N; Goessaert AS; Fonteyne V; De Troyer B; Jacobs F; De Meerleer G
    Eur Urol; 2011 Oct; 60(4):842-9. PubMed ID: 21514039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy.
    Moll M; D'Andrea D; Zaharie A; Grubmüller B; Paschen C; Zehetmayer S; Shariat SF; Widder J; Goldner G
    Strahlenther Onkol; 2022 Aug; 198(8):719-726. PubMed ID: 35284951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
    Abu-Gheida I; Reddy CA; Kotecha R; Weller MA; Shah C; Kupelian PA; Mian O; Ciezki JP; Stephans KL; Tendulkar RD
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):325-333. PubMed ID: 30721720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.